Copyright Reports & Markets. All rights reserved.

Global Migraine Headache Drugs Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Migraine Headache Drugs Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Migraine Headache Drugs Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Almotriptan
      • 1.4.3 Eletriptan
      • 1.4.4 Sumatriptan
      • 1.4.5 Rizatriptan
      • 1.4.6 Zolmitriptan
      • 1.4.7 Naratriptan
      • 1.4.8 Frovatriptan
      • 1.4.9 Others
    • 1.5 Market by Application
      • 1.5.1 Global Migraine Headache Drugs Market Share by Application: 2020 VS 2026
      • 1.5.2 Acute Migraine
      • 1.5.3 Common Migraine
      • 1.5.4 Classic Migraine
      • 1.5.5 Chronic Migraine
      • 1.5.6 Other Migraines
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Migraine Headache Drugs Market Perspective (2015-2026)
    • 2.2 Migraine Headache Drugs Growth Trends by Regions
      • 2.2.1 Migraine Headache Drugs Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Migraine Headache Drugs Historic Market Share by Regions (2015-2020)
      • 2.2.3 Migraine Headache Drugs Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Migraine Headache Drugs Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Migraine Headache Drugs Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Migraine Headache Drugs Players by Market Size
      • 3.1.1 Global Top Migraine Headache Drugs Players by Revenue (2015-2020)
      • 3.1.2 Global Migraine Headache Drugs Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Migraine Headache Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Migraine Headache Drugs Market Concentration Ratio
      • 3.2.1 Global Migraine Headache Drugs Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Migraine Headache Drugs Revenue in 2019
    • 3.3 Migraine Headache Drugs Key Players Head office and Area Served
    • 3.4 Key Players Migraine Headache Drugs Product Solution and Service
    • 3.5 Date of Enter into Migraine Headache Drugs Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Migraine Headache Drugs Historic Market Size by Type (2015-2020)
    • 4.2 Global Migraine Headache Drugs Forecasted Market Size by Type (2021-2026)

    5 Migraine Headache Drugs Breakdown Data by Application (2015-2026)

    • 5.1 Global Migraine Headache Drugs Market Size by Application (2015-2020)
    • 5.2 Global Migraine Headache Drugs Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Migraine Headache Drugs Market Size (2015-2020)
    • 6.2 Migraine Headache Drugs Key Players in North America (2019-2020)
    • 6.3 North America Migraine Headache Drugs Market Size by Type (2015-2020)
    • 6.4 North America Migraine Headache Drugs Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Migraine Headache Drugs Market Size (2015-2020)
    • 7.2 Migraine Headache Drugs Key Players in Europe (2019-2020)
    • 7.3 Europe Migraine Headache Drugs Market Size by Type (2015-2020)
    • 7.4 Europe Migraine Headache Drugs Market Size by Application (2015-2020)

    8 China

    • 8.1 China Migraine Headache Drugs Market Size (2015-2020)
    • 8.2 Migraine Headache Drugs Key Players in China (2019-2020)
    • 8.3 China Migraine Headache Drugs Market Size by Type (2015-2020)
    • 8.4 China Migraine Headache Drugs Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Migraine Headache Drugs Market Size (2015-2020)
    • 9.2 Migraine Headache Drugs Key Players in Japan (2019-2020)
    • 9.3 Japan Migraine Headache Drugs Market Size by Type (2015-2020)
    • 9.4 Japan Migraine Headache Drugs Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Migraine Headache Drugs Market Size (2015-2020)
    • 10.2 Migraine Headache Drugs Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Migraine Headache Drugs Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Migraine Headache Drugs Market Size by Application (2015-2020)

    11 India

    • 11.1 India Migraine Headache Drugs Market Size (2015-2020)
    • 11.2 Migraine Headache Drugs Key Players in India (2019-2020)
    • 11.3 India Migraine Headache Drugs Market Size by Type (2015-2020)
    • 11.4 India Migraine Headache Drugs Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Migraine Headache Drugs Market Size (2015-2020)
    • 12.2 Migraine Headache Drugs Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Migraine Headache Drugs Market Size by Type (2015-2020)
    • 12.4 Central & South America Migraine Headache Drugs Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 Pfizer
      • 13.1.1 Pfizer Company Details
      • 13.1.2 Pfizer Business Overview and Its Total Revenue
      • 13.1.3 Pfizer Migraine Headache Drugs Introduction
      • 13.1.4 Pfizer Revenue in Migraine Headache Drugs Business (2015-2020))
      • 13.1.5 Pfizer Recent Development
    • 13.2 Novartis
      • 13.2.1 Novartis Company Details
      • 13.2.2 Novartis Business Overview and Its Total Revenue
      • 13.2.3 Novartis Migraine Headache Drugs Introduction
      • 13.2.4 Novartis Revenue in Migraine Headache Drugs Business (2015-2020)
      • 13.2.5 Novartis Recent Development
    • 13.3 Johnson & Johnson
      • 13.3.1 Johnson & Johnson Company Details
      • 13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
      • 13.3.3 Johnson & Johnson Migraine Headache Drugs Introduction
      • 13.3.4 Johnson & Johnson Revenue in Migraine Headache Drugs Business (2015-2020)
      • 13.3.5 Johnson & Johnson Recent Development
    • 13.4 GSK
      • 13.4.1 GSK Company Details
      • 13.4.2 GSK Business Overview and Its Total Revenue
      • 13.4.3 GSK Migraine Headache Drugs Introduction
      • 13.4.4 GSK Revenue in Migraine Headache Drugs Business (2015-2020)
      • 13.4.5 GSK Recent Development
    • 13.5 Merck
      • 13.5.1 Merck Company Details
      • 13.5.2 Merck Business Overview and Its Total Revenue
      • 13.5.3 Merck Migraine Headache Drugs Introduction
      • 13.5.4 Merck Revenue in Migraine Headache Drugs Business (2015-2020)
      • 13.5.5 Merck Recent Development
    • 13.6 Eli Lilly
      • 13.6.1 Eli Lilly Company Details
      • 13.6.2 Eli Lilly Business Overview and Its Total Revenue
      • 13.6.3 Eli Lilly Migraine Headache Drugs Introduction
      • 13.6.4 Eli Lilly Revenue in Migraine Headache Drugs Business (2015-2020)
      • 13.6.5 Eli Lilly Recent Development
    • 13.7 Teva
      • 13.7.1 Teva Company Details
      • 13.7.2 Teva Business Overview and Its Total Revenue
      • 13.7.3 Teva Migraine Headache Drugs Introduction
      • 13.7.4 Teva Revenue in Migraine Headache Drugs Business (2015-2020)
      • 13.7.5 Teva Recent Development
    • 13.8 AstraZeneca
      • 13.8.1 AstraZeneca Company Details
      • 13.8.2 AstraZeneca Business Overview and Its Total Revenue
      • 13.8.3 AstraZeneca Migraine Headache Drugs Introduction
      • 13.8.4 AstraZeneca Revenue in Migraine Headache Drugs Business (2015-2020)
      • 13.8.5 AstraZeneca Recent Development
    • 13.9 Sun Pharma
      • 13.9.1 Sun Pharma Company Details
      • 13.9.2 Sun Pharma Business Overview and Its Total Revenue
      • 13.9.3 Sun Pharma Migraine Headache Drugs Introduction
      • 13.9.4 Sun Pharma Revenue in Migraine Headache Drugs Business (2015-2020)
      • 13.9.5 Sun Pharma Recent Development
    • 13.10 Grunenthal
      • 13.10.1 Grunenthal Company Details
      • 13.10.2 Grunenthal Business Overview and Its Total Revenue
      • 13.10.3 Grunenthal Migraine Headache Drugs Introduction
      • 13.10.4 Grunenthal Revenue in Migraine Headache Drugs Business (2015-2020)
      • 13.10.5 Grunenthal Recent Development
    • 13.11 Endo Pharmaceuticals
      • 10.11.1 Endo Pharmaceuticals Company Details
      • 10.11.2 Endo Pharmaceuticals Business Overview and Its Total Revenue
      • 10.11.3 Endo Pharmaceuticals Migraine Headache Drugs Introduction
      • 10.11.4 Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2015-2020)
      • 10.11.5 Endo Pharmaceuticals Recent Development
    • 13.12 Mylan
      • 10.12.1 Mylan Company Details
      • 10.12.2 Mylan Business Overview and Its Total Revenue
      • 10.12.3 Mylan Migraine Headache Drugs Introduction
      • 10.12.4 Mylan Revenue in Migraine Headache Drugs Business (2015-2020)
      • 10.12.5 Mylan Recent Development
    • 13.13 Bayer
      • 10.13.1 Bayer Company Details
      • 10.13.2 Bayer Business Overview and Its Total Revenue
      • 10.13.3 Bayer Migraine Headache Drugs Introduction
      • 10.13.4 Bayer Revenue in Migraine Headache Drugs Business (2015-2020)
      • 10.13.5 Bayer Recent Development
    • 13.14 Amneal Pharmaceuticals
      • 10.14.1 Amneal Pharmaceuticals Company Details
      • 10.14.2 Amneal Pharmaceuticals Business Overview and Its Total Revenue
      • 10.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Introduction
      • 10.14.4 Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2015-2020)
      • 10.14.5 Amneal Pharmaceuticals Recent Development
    • 13.15 Apotex
      • 10.15.1 Apotex Company Details
      • 10.15.2 Apotex Business Overview and Its Total Revenue
      • 10.15.3 Apotex Migraine Headache Drugs Introduction
      • 10.15.4 Apotex Revenue in Migraine Headache Drugs Business (2015-2020)
      • 10.15.5 Apotex Recent Development
    • 13.16 Ajanta Pharma
      • 10.16.1 Ajanta Pharma Company Details
      • 10.16.2 Ajanta Pharma Business Overview and Its Total Revenue
      • 10.16.3 Ajanta Pharma Migraine Headache Drugs Introduction
      • 10.16.4 Ajanta Pharma Revenue in Migraine Headache Drugs Business (2015-2020)
      • 10.16.5 Ajanta Pharma Recent Development
    • 13.17 Allergan
      • 10.17.1 Allergan Company Details
      • 10.17.2 Allergan Business Overview and Its Total Revenue
      • 10.17.3 Allergan Migraine Headache Drugs Introduction
      • 10.17.4 Allergan Revenue in Migraine Headache Drugs Business (2015-2020)
      • 10.17.5 Allergan Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Migraine Headache Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Migraine Headache Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Pfizer
      Novartis
      Johnson & Johnson
      GSK
      Merck
      Eli Lilly
      Teva
      AstraZeneca
      Sun Pharma
      Grunenthal
      Endo Pharmaceuticals
      Mylan
      Bayer
      Amneal Pharmaceuticals
      Apotex
      Ajanta Pharma
      Allergan

      Market segment by Type, the product can be split into
      Almotriptan
      Eletriptan
      Sumatriptan
      Rizatriptan
      Zolmitriptan
      Naratriptan
      Frovatriptan
      Others
      Market segment by Application, split into
      Acute Migraine
      Common Migraine
      Classic Migraine
      Chronic Migraine
      Other Migraines

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Migraine Headache Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Migraine Headache Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Migraine Headache Drugs are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now